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Abstract
Repeat cesarean sections (CS) are associated with additional risks of perioperative complications. 
The aim of our study was ultrasound evaluation of uterine involution in women after repeat traditional cesarean delivery and 
after repeat CS using argon plasma coagulation and prophylactic use of tranexamic acid and carbetocin.
Materials and methods. Prospective cohort study has been conducted on 140 patients who underwent second CS. Group 
I included 70 women who had repeat CS with the use of argon plasma coagulation and administration of 100 mcg carbetocin after 
cutting the umbilical cord. Ten minutes before the operation, 15 mg/kg of tranexamic acid was injected intravenously. Group II con-
sisted of 70 women who had traditional CS, slow intravenous infusion of 10 IU of oxytocin, divided between 5 UI intravenous bolus 
dose and slow intravenous infusion, was administered after delivery of the baby. A serial ultrasonographic examination was carried 
out on the 2nd and 5th day of the postpartum period. 
Results. A study of the dynamics of changes in uterine body and uterine cavity volume revealed a faster rate of uterine cavity 
involution in group I compared with group II (p < 0.05). In group I on the 5th day in comparison to the 2nd day the mean uterine body 
volume decreased by 27.75 %, in group II – by 20.17 %. In group I mean uterine cavity volume declined in three days by 21.09 %, in 
group II – 14.22 %. Uterine subinvolution was diagnosed in 3 (4.29 %) cases in group I and in 19 (27.14 %) cases in group II (p < 0.05). 
Faster uterine involution in group I is probably associated with techniques, that were applied during intraoperative period. In ad-
dition, 2.86 % (2 cases) from the group I versus 31.43 % (22 cases) from the group II, needed additional uterotonic therapy after 
surgery (methylergometrine, misoprostol) (p < 0.001).
Conclusion. We have found differences in the course of uterine involution in women in group I in comparison with group II, 
such as significantly smaller uterine length on the 2nd and 5th day, significantly smaller uterine body and uterine cavity volume, faster 
rates of involution of the uterine cavity during the first 5 days of the postpartum period, thinner anterior uterine wall in the sutured area. 
We therefore conclude that complex use of tranexamic acid, carbetocin and argon plasma coagulation appears to be effective 
to maintain adequate uterine involution after repeat CS and prevent postoperative complications. 
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1. Introduction
The rate of cesarean delivery in Ukraine, the same as in other countries, does not tend to 
decrease and it ranges from 11 % to 29 %, reaching even more than 50 % in perinatal centers. 
Repeat cesarean sections (CS) are associated with additional risks of perioperative complications. 
Bleeding and uterine atony take the first place among complications of the intraoperative period. 
The most frequent complications of postoperative period are uterine subinvolution, endometritis, 
wound suppuration and hematomas [1, 2]. Fever and endometritis is relatively frequent after 
CS (1.7–11 %), compared with vaginal delivery (1–2 %) [3].
The rate of uterine involution is one of the important prognostic criteria for the course of the 
postpartum period. Subinvolution is one of the earliest clinical manifestations of the pathological 
course of the postpartum period. According to a literature review, the rate of subinvoluted uterus 
varies from 11 % to 51.5 % of all postpartum pathology [4].
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Slower process of uterine involution, especially in the first week of the postpartum period, 
contributes to the risk for developing septic complications.
For this reason accurate and timely diagnosis of uterine subinvolution is very important. 
Ultrasound of uterine is a useful tool after delivery and is important in facilitating an early de-
tection of postpartum uterine complications. Pelvic ultrasound is accurate, safe, non-invasive and 
affordable method of controlling of uterine involution. Therefore a serial ultrasound examination 
of the uterus after delivery is helpful in the assessment of uterine shape, position, size, volume and 
cavity, as well as in the diagnosis of subinvolution. In the early postpartum period the transabdomi-
nal approach is recommended. The uterus naturally regresses during the puerperium, with the most 
rapid involution occurring during the first week [5, 6].
The aim of our study was ultrasound evaluation of uterine involution in women after repeat 
traditional cesarean delivery and after repeat CS using argon plasma coagulation and prophylactic 
use of tranexamic acid and carbetocin.
2. Material and methods
Prospective cohort study has been conducted on 140 patients who underwent repeat CS be-
tween January 2018 and December 2019 at the clinical base of the Department of Obstetrics and Gy-
necology No 1 Shupyk National Medical Academy of Postgraduate Education (Kyiv Regional Perina-
tal Center). Group I included 70 women who had repeat CS with the use of argon plasma coagulation 
and administration of 100 mcg carbetocin after cutting the umbilical cord. Ten minutes before the 
operation, 15 mg/kg of tranexamic acid was injected intravenously. Group II consisted of 70 women 
who had traditional CS, slow intravenous infusion of 10 IU of oxytocin, divided between 5 UI intra-
venous bolus dose and slow intravenous infusion, was administered after delivery of the baby.
Written informed consent was obtained from all women. The study was evaluated and ap-
proved by Shupyk National Medical Academy of Postgraduate Education Ethics Commission (pro-
tocol No. 1, 03.01.2017), keeping in view Helsinki declaration.
In both groups Joel-Cohen incision was used, all uterine incisions were low transverse type, 
double-layer uterine closure was done. All women underwent spinal anaesthesia. All women re-
ceived prophylactic antibiotics. Interval between CSs in both groups was 2–5 years.
The inclusion criteria were: women after one prior lower segment cesarean section, without 
any mental disorders or congenital diseases, 39–40 weeks gestation, one live fetus in the uterus, 
maternal refusal of vaginal delivery, localization of placenta outside the uterine scar.
The exclusion criteria were: preterm or multiple pregnancy, stillbirth, congenital uterine dis-
orders (bicornuate or unicornuate uterus, double uterus), uterine fibroids or oncological diseases, 
severe concomitant pathology, premature rupture of membranes, varicose veins in the pelvic re-
gion, localization of placenta in the uterine scar area.
There was no statistically significant difference in the women’s age, social status, parity and 
health status.
All ultrasound examinations were performed on Kontron Imagic Agile ultrasound machine 
with the use of transabdominal probe with frequencies ranging from 2.5 to 6 MHz and transvaginal 
probe with frequencies ranging from 5 to 8 MHz.
A serial ultrasonographic examination was carried out on the 2nd and 5th day of the postpar-
tum period. Each woman was examined 2 times.
An abdominal ultrasound scan was carried out on the 2nd and 5th day after delivery in order 
to assess the rate of uterine involution. Uterine measurements included: 1) the length of the uterus, 
the distance between the internal cervical os and the top of the uterine fundus; 2) the anteropos-
terior diameter was measured in the widest part of the longitudinal section, perpendicular to the 
longitudinal uterine axis – the distance; 3) the uterine width was measured on a transverse section 
through the uterine body where it appeared to be at its widest [7]. We evaluated the uterine loca-
tion, contours, echotexture and echogenicity of the anterior wall of the uterus in the sutured area, 
condition of uterus suture, endometrial contents. 
Since recent years, it has been thought that the most objective process of uterine involution 
can be evaluated in case of monitoring the dynamics of volume change, so we decided to investigate 
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this parameter as well. Ultrasound machine automatically calculated the uterine volume based on 
three orthogonal measurements (the length, the antero-posterior diameter and the width). The same 
parameters of the uterine cavity were also measured (the length, the antero-posterior diameter and 
the width).
During ultrasound examination the presence of blood clots in the uterine cavity was taken 
into account, since these parameters characterize sufficient uterine contractility and postpartum 
self-purification processes of uterus.
Results are presented as mean ± standart deviation. Data were tested for normal distribution. 
Student t-test was used for comparison between groups. Chi-square test was used for comparison 
between groups as regard qualitative variables. P-value of less then 0.05 was considered as statisti-
cally significant. The STATISTICA software version 10 for WINDOWS was used for the statistical 
calculations.
3. Results
All relevant maternal subject characteristics in both study groups were comparable, none 
previous abdominal surgery, except cesarean section.
In all cases the indication to CS procedure was uterine scar after previous CS. Mean age of 
women in group I was 34.09 ± 6.38 (22-38) years, in group II – 36.71. ± 3.64 (21–36) years. Mean 
body mass index in group I 27.16 ± 2.88, in group II – 27.61 ± 3.55 (p = 0.721). Interval between CSs 
in group I was 3.42 ± 2.06, in group II – 4.45 ± 2.62 years (p = 0.757). Mean infant birth weight in 
group I was 3324.64 ± 312.37 grams and in group II – 3374.05 ± 339.15 grams (p = 0.914).
The results are presented in Tables 1–3.
Table 1
Median characteristics  ±  standard deviation of the uterine size (mm)
Uterine size Group I (n = 70) Group II (n = 70) p-value
Uterus length (mm) 2nd day 125.45 ± 6.73 143.32 ± 4.58 0.029
5th day 109.54 ± 7.41 129.48 ± 6.82 0.049
Uterus width (mm) 2nd day 112.91 ± 6.28 127.25 ± 6.15 0.105
5th day 97.12 ± 7.47 115.68 ± 7.63 0.084
Anteroposterior diameter (mm) 2nd day 70.20 ± 4.03 78.09 ± 3.71 0.152
5th day 61.09 ± 3.31 71.65 ± 6.24 0.137
Table 2
Changing of the anteroposterior diameter of the uterine cavity (mm)
Anteroposterior  
diameter (mm) Group I (n = 70) Group II (n = 70) p-value
2nd day 7.84 ± 0.75 10.17 ± 1.22 0.106
5th day 3.25 ± 1.56 6.35 ± 1.17 0.114
Table 3
Changing of the uterine volume (cm3)
Group
Uterine body volume (cm3) Uterine cavity volume (cm3)
2nd day 5th day 2nd day 5th day
Group I (n = 70) 524.95 ± 53.12 379.30 ± 55.62 31.3 ± 3.6 24.7 ± 4.4
Group II (n = 70) 672.09 ± 51.13 536.58 ± 52.84 42.2 ± 4.1 36.2 ± 3.8
p-value 0.047 0.042 0.047 0.049
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The mean uterus parameters are smaller in group I, and the decreasing trend is faster. 
In group I mean uterus length decreased in three days by 12.69 %, uterus width – by 13.99 %, 
anteroposterior diameter – 12.98 %, in group II mean uterus length decreased by 9.66 %, uterus 
width – by 9.10 %, anteroposterior diameter – by 8.25 %, respectively.
The dynamic determination of uterine volume the most accurate reflects its involution after 
cesarean section. It should be noted that when evaluating different parameters of uterine involution, 
from our point of view, the most indicative for diagnostics is the assessment of the dynamics of 
changing of the uterine volume and the volume of the uterine cavity, especially in the first 5 days 
of puerperium. We have found a significant difference in the rate of uterine body and cavity vol-
ume involution in groups I and II (p < 0.05). A study of the dynamics of changes in uterine body 
and uterine cavity volume (Table 3) revealed a slower rate of uterine cavity involution in group II 
compared with group I. In group I on the 5th day in comparison to the 2nd day the mean uterine 
body volume decreased by 27.75 %, in group II – by 20.17 %. In group I mean uterine cavity volume 
declined in three days by 21.09 %, in group II – 14.22 %. 
The study confirmed that women in group II had insufficient rates of uterine cavity invo-
lution against the background of decreased uterine body volume. Uterine involution in women 
of group II was due to myometrium, while the size of the uterine cavity had insufficient rates of 
reverse development, which may increase the risk of inflammatory complications in this group 
of women. Faster uterine involution in group I is probably associated with techniques, that were 
applied during intraoperative period.
In 2 cases in group I and in 5 cases in group II small hematomas (< 15 mm) along the suture 
line were found and were considered as normal. It was seen as a non-vascular mass of mixed echo-
genicity, anterior to the uterus and posterior to the bladder. Because of they were less than 4 cm in 
size, they were considered normal [8, 9].
Blood clots were found in the uterine cavity on the 5th day in group I in 4 (5.71 %) and in 
group II in 12 (17.14 %) (p < 0.05). In 7 cases in group II vacuum aspiration to remove uterine con-
tents was performed. 
Uterine subinvolution was diagnosed in 3 (4.29 %) cases in group I and in 19 (27.14 %) cases 
in group II (p < 0.05).
Mean anterior uterine wall thickness in the sutured area on the 5th day in group I was 
15.01 ± 2.68 mm, in group II – 21.68 ± 1.73 mm (p = 0.038). Thinner anterior uterine wall in group I 
could be a result of anti-exudative effect of argon plasma coagulation of uterine suture. The 
hypoechoic fluid inserts at the scar location tended to be more frequent in group II compared with 
group I 14 (20 %) cases versus 3 (4.29 %), respectively, p < 0.05). This may be associated with the 
increased uterine contractility in group I due to the effect of carbetocin and argon plasma coagu-
lation of uterine suture. Though, the hypoechoic stripe within the scar does not mean incomplete 
healing [10]. The largest changes of the scar occur within the first month after CS, for this reason 
further observation is required.
In addition, 2.86 % (2 cases) from the group I versus 31.43 % (22 cases) from the group II, 
needed additional uterotonic therapy after surgery (methylergometrine, misoprostol) (p < 0.001). Con-
sequently, significantly more patients required additional oxytocics in the second group. Tranexamic 
acid was given in 20 cases in group II during operation for postpartum hemorrhage treatment.
4. Discussion
Obstetric hemorrhage, especially postpartum hemorrhage, is responsible for more than 
a quarter of all maternal deaths worldwide [11].
The course of the postoperative period and repair process is determined by a significant 
number of factors, which include: the state of the macroorganism, the surgery technique, suture 
material, duration of operation, the amount of blood loss. The achievement of adequate intraopera-
tive haemostasis is important in prevention of acute complications after Cesarean delivery. For this 
reason mmodern obstetrics reveals an indisputable interest in the improvement of the techniques 
of performing the operation of repeat CS using the electrosurgical technology, modern intravenous 
hemostatic and uterotonic agents.
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The results of meta-analysis indicate that double-layer unlocked closure is preferable to 
single-layer locked closure regarding residual myometrium thickness and scar healing ratio [12].
Argon plasma coagulation – is a monopolar noncontact electrosurgical procedure which 
uses ionized argon gas to conduct electrical current from the probe to the tissue. This method 
allows cutting tissue with effective hemostasis, has a local antibacterial action and improves local 
reparative processes. Argon plasma coagulation means less blood loss and less tissue damage, with 
penetration depth limited to 3 mm. Tissue carbonization is minimal compared to standard elec-
trocoagulation [13]. Argon plasma energy removes the risk of arcing, alternate side burns, lateral 
heat effects, and surface carbonization is barely visible [14, 15] reported in their study that using 
argon plasma coagulation during CS reduces the amount of wound exudate and helps to improve 
microcirculation and tissue repair.
Besides the electrosurgery, the use of systemic antifibrinolytic agents, namely tranexamic 
acid, is of particular importance. It was authenticated that during surgery the haemostatic balance 
can change toward increased fibrinolysis, leading to coagulopathy and bleeding. Tranexamic acid 
reduces bleeding by inhibiting the enzymatic breakdown of fibrinogen and fibrin by plasmin and it 
has been recognized to decrease blood loss and transfusion needs in various elective surgeries and 
in post-partum haemorrhage [16, 17].
At the same time, uterotonics, agents used to increase myometrial tone and contractility, are 
the first-line treatment for postpartum hemorrhage. Despite the fact that the oxytocin is the most 
widely used uterotonic agent, it has some disadvantages. Since oxytocin has a very short plasma 
half-life (1–6 min), its administration is required not only during surgery but also in the early post-
operative period, when most postpartum bleeding occurs.
In addition, intravenous administration requires 40 minutes to reach a steady-state concen-
tration [18]. At the same time carbetocin is devoid of these disadvantages. Carbetocin is a long- 
acting synthetic oxytocin analogue and is characterized by a rapid onset of action and a long half-
life (approximately 40 minutes). Uterine contractions occur in less than two minutes after intrave-
nous administration of optimal dosage of 100 mcg [19]. According to the literature data, a single 
dose of carbetocin has stronger and longer lasting effect and is more economically viable than 
oxytocin [20, 21].
The trials revealed that using timely prophylactic uterotonics could be helpful [22] and that 
tranexamic acid as an antifibrinolytic drug could help the bleeding [23]. According to recommen-
dations of WHO, 2018 preventive use of carbetocin is associated with a substantial reduction in 
postpartum haemorrhage, blood transfusion and the use of additional uterotonics when compared 
with placebo or no uterotonic.
However, the complex effect of the use of argon plasma tissue coagulation in combination 
with uterotonic and hemostatic agents on the course of the postoperative period of re-cesarean 
section has not been studied yet.
There are very few studies showing uterine involution after CS. The strengths of our study 
are following: the research, from the beginning to the end, was conducted by one person; the same 
person assisted the women during surgery; an explanation of the differences observed between two 
approaches is provided.
An average uterine size on day 7 after delivery are: length – 129 mm, width – 94 mm, ante-
rior-posterior diameter – 78 mm. Our results show faster uterine involution. This probably can be 
explained by the use of modern uterotonics and technical support during surgery.
Extensive blood loss causing surgical difficulties could theoretically affect the healing pro-
cess and uterine involution negatively. In the Cochrane (2016) regarding «Carbetocin versus oxy-
tocin for prevention of postpartum haemorrhage» is concluded that the use of carbetocin is more 
effective than oxytocin for preventing postpartum haemorrhage [24].
Our findings suggest that complex use of argon plasma coagulation, tranexemic acid and 
carbetocin has a marked effect on uterine involution.
Of course, there are some limitations of this study: small number of women in both groups, 
no results of further postpartum investigation and study of possible chronic complications. The 
present findings of this study are observational and too narrow to draw more comprehensive 
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conclusions. We are planning to continue our research in the future with further observation in the 
delayed postpartum period.
5. Conclusion
Ultrasound assessment and comparison of the course of uterine involution in group I in 
comparison with group II with a significant difference revealed the following characteristics: 
1. significantly smaller uterine body length on the 2nd (125.45 ± 6.73 mm vs. 143.32 ± 4.58 mm, 
p = 0.029) and 5th day after caesarean section (109.54 ± 7.41 mm vs. 129.48 ± 6.82 mm, p = 0.049).
2. smaller uterine body volume (524.95 ± 53.12 cm3 vs. 672.09 ± 51.13 cm3 on the 2nd day, 
p = 0.047 and 379.30 ± 55.62 cm3 vs. 536.58 ± 52.84 cm3 on the 5th day, p = 0.042) and the uterine 
cavity volume (31.3 ± 3.6 cm3 against 42.2 ± 4.1 cm3 on the 2nd day, p = 0.047 and 24.7 ± 4.4 cm3 
against 36.2 ± 3.8 cm3 on the 5th day, p = 0.049). 
3. thinner anterior uterine wall in the sutured area on the 5th day of the postoperative period 
(15.01 ± 2.68 mm vs. 21.68 ± 1.73 mm, p = 0.038).
4. the hypoechoic fluid inserts at the scar location tended to be less often in group I com-
pared with group II – 3 (4.29 %) cases versus 14 (20 %), p < 0.05.
5. Uterine subinvolution was diagnosed significantly less frequently in group I (3 (4.29 %) 
cases versus 19 (27.14 %), p < 0.05.
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